Jacob Gottlieb, MD, CFA, PRM is the Managing Partner and Chief Investment Officer of Altium Capital Management, which he founded in 2017. Jacob has over 20 years of hedge fund, private equity, and venture capital investing experience, including developing successful teams of investment professionals and business management staff.
Prior to founding Altium, Dr. Gottlieb founded Visium Asset Management in 2005, a successful spinout from Balyasny Asset Management. Under his leadership, Visium grew to approximately $8 billion AUM, employing over 175 people in US & EU, and became one of the premier healthcare investors in the world – managing assets for public and private pension funds, corporate investment offices, endowments and foundations, and ultra high net worth families. As Chief Investment Officer, he led a team of more than 85 investment professionals and developed institutional-level investment processes. Visium’s flagship product, Visium Balanced Fund (healthcare focused equities) generated industry-leading results, including peak assets under management of approximately $4 billion and approximately 15% average annual returns from 2001 to 2015 on a market-neutral portfolio.
Dr. Gottlieb led the creation and Visium launched other public equity and credit hedge fund products, a UCITS fund for European investors, a 40-Act alternative mutual fund, and customized products for key institutional investors. Additionally, Visium acquired and re-launched other hedge fund and private equity products, including the product that was launched as Visium Healthcare Partners, a specialty finance business focused on royalties for commercialized therapeutics (subsequently spun out to become Madryn Asset Management).
Prior to founding Visium, Dr. Gottlieb was the Healthcare Portfolio Manager and Partner at Balyasny Asset Management where he built his team to over 20 investment professionals, then spinning out to form Visium. Before joining Balyasny, he was a Portfolio Manager at Merlin BioMed, where he contributed to a 200% gross return in a single year. Dr. Gottlieb started his investment career as a buyside analyst at Sanford C. Bernstein (now AllianceBernstein), covering global healthcare.
Dr. Gottlieb graduated magna cum laude from Brown University, then attended New York University Medical School earning his medical degree in 1997. He obtained his CFA charter in 2001, and his PRM designation from the Professional Risk Managers' International Association in 2010.